N-(2-bromobenzyl)-3-methoxybenzo[b]thiophene-2-carboxamide

ID: ALA5288309

Max Phase: Preclinical

Molecular Formula: C17H14BrNO2S

Molecular Weight: 376.27

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COc1c(C(=O)NCc2ccccc2Br)sc2ccccc12

Standard InChI:  InChI=1S/C17H14BrNO2S/c1-21-15-12-7-3-5-9-14(12)22-16(15)17(20)19-10-11-6-2-4-8-13(11)18/h2-9H,10H2,1H3,(H,19,20)

Standard InChI Key:  OXYLVGDHKRSNCU-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 22 24  0  0  0  0  0  0  0  0999 V2000
   -3.1957   -0.6138    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1968   -1.4388    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4841   -1.8505    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4859   -0.2022    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7725   -0.6102    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7677   -1.4388    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9782   -1.6903    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4950   -1.0170    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9860   -0.3496    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7364    0.4341    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0671    0.6099    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3275   -1.0122    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7430   -1.7221    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.7347   -0.2973    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.5573   -0.2925    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9643    0.4222    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7855    0.4257    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1925    1.1396    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7770    1.8505    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9501    1.8430    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5469    1.1285    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1968   -0.2867    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  4  1  1  0
  5  4  2  0
  3  6  2  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9  5  1  0
  9 10  1  0
 10 11  1  0
  8 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 16  1  0
 17 22  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5288309

    ---

Associated Targets(Human)

CFTR Tclin Cystic fibrosis transmembrane conductance regulator (2075 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 376.27Molecular Weight (Monoisotopic): 374.9929AlogP: 4.60#Rotatable Bonds: 4
Polar Surface Area: 38.33Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 4.39CX LogD: 4.39
Aromatic Rings: 3Heavy Atoms: 22QED Weighted: 0.72Np Likeness Score: -1.46

References

1. Spanò V, Venturini A, Genovese M, Barreca M, Raimondi MV, Montalbano A, Galietta LJV, Barraja P..  (2020)  Current development of CFTR potentiators in the last decade.,  204  [PMID:32898816] [10.1016/j.ejmech.2020.112631]

Source